126 related articles for article (PubMed ID: 2123429)
1. Abnormalities of CD4+ T lymphocyte proliferative responses from patients with recently diagnosed insulin-dependent diabetes mellitus.
al-Kassab AS; Raziuddin S
Diabetes Res Clin Pract; 1990; 10(1):45-9. PubMed ID: 2123429
[TBL] [Abstract][Full Text] [Related]
2. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus.
al-Kassab AS; Raziuddin S
Clin Exp Immunol; 1990 Aug; 81(2):267-71. PubMed ID: 1696864
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.
Ilonen J; Surcel HM; Käär ML
Clin Exp Immunol; 1991 Aug; 85(2):278-81. PubMed ID: 1677834
[TBL] [Abstract][Full Text] [Related]
4. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives.
Kaaba SA; Al-Harbi SA
Immunol Lett; 1995 Sep; 47(3):209-13. PubMed ID: 8747721
[TBL] [Abstract][Full Text] [Related]
5. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
[TBL] [Abstract][Full Text] [Related]
6. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus.
Petersen LD; Duinkerken G; Bruining GJ; van Lier RA; de Vries RR; Roep BO
J Autoimmun; 1996 Dec; 9(6):731-7. PubMed ID: 9115575
[TBL] [Abstract][Full Text] [Related]
7. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients.
Moreno-Lafont MC; López-Santiago R; Zumarán-Cuéllar E; Paredes-Cervantes V; López-Merino A; Estrada-Aguilera A; Santos-Argumedo L
Trans R Soc Trop Med Hyg; 2002; 96(3):340-7. PubMed ID: 12174793
[TBL] [Abstract][Full Text] [Related]
9. 5-bromodeoxyuridine-light inactivation of human lymphocytes stimulated mitogens and allogeneic cells: evidence for distinct T-lymphocyte subsets.
Touraine JL; Touraine F; Hadden JW; Hadden EM; Good RA
Int Arch Allergy Appl Immunol; 1976; 52(1-4):105-17. PubMed ID: 1087917
[TBL] [Abstract][Full Text] [Related]
10. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
[TBL] [Abstract][Full Text] [Related]
11. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM.
Smerdon RA; Peakman M; Hussain MJ; Alviggi L; Watkins PJ; Leslie RD; Vergani D
Diabetes; 1993 Jan; 42(1):127-33. PubMed ID: 8420810
[TBL] [Abstract][Full Text] [Related]
12. Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes.
Peakman M; Hussain MJ; Millward BA; Leslie RD; Vergani D
Diabet Med; 1990 May; 7(4):327-30. PubMed ID: 2140085
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes.
Biselli R; Matricardi PM; D'Amelio R; Fattorossi A
Scand J Immunol; 1992 Apr; 35(4):439-47. PubMed ID: 1373002
[TBL] [Abstract][Full Text] [Related]
15. Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin-dependent diabetes mellitus.
Gupta S; Charles MA; Waldeck N; Kershnar A; Buckingham B
Diabetes Res; 1986 Jun; 3(5):225-9. PubMed ID: 2943547
[TBL] [Abstract][Full Text] [Related]
16. Activated CD4+ and CD8+ T-lymphocytes in newly diagnosed type 1 diabetes: a prospective study.
Buschard K; Damsbo P; Röpke C
Diabet Med; 1990 Feb; 7(2):132-6. PubMed ID: 2137753
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood lymphocytes of nonleukemic lymphoma patients exhibit aberrant expression of T-cell activation markers after polyclonal stimulation in vitro.
Mangge H; Beaufort F; Neubauer M; Samitz M; Schauenstein K
Cancer; 1990 Aug; 66(4):677-83. PubMed ID: 2386899
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of the interleukin 2 system in children with IDDM.
Tomoda T; Kurashige T; Taniguchi T
Diabetologia; 1994 May; 37(5):476-82. PubMed ID: 8056185
[TBL] [Abstract][Full Text] [Related]
19. Role of CD4 and CD8 in enhancing T-cell responses to antigen.
Parnes JR; von Hoegen P; Miceli MC; Zamoyska R
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():649-55. PubMed ID: 2518008
[No Abstract] [Full Text] [Related]
20. Cell-mediated immunity and biological response modifiers in insulin-dependent diabetes mellitus complicated by end-stage renal disease.
Attallah AM; Abdelghaffar H; Fawzy A; Alghraoui F; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
Int Arch Allergy Appl Immunol; 1987; 83(3):278-83. PubMed ID: 3110074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
